
The aromatase inhibitor letrozole produces the same number of mature preovulatory follicles and results in a similar pregnancy rate as clomiphene citrate in women with unexplained fertility undergoing gonadotropin-stimulated controlled ovarian hyperstimulation cycles combined with intrauterine insemination (IUI) therapy. That's the conclusion of a new randomized, blinded trial conducted in Mexico.